LT3573948T - Citotoksinių benzodiazepino darinių paruošimo būdai - Google Patents

Citotoksinių benzodiazepino darinių paruošimo būdai

Info

Publication number
LT3573948T
LT3573948T LTEPPCT/US2018/014956T LT18014956T LT3573948T LT 3573948 T LT3573948 T LT 3573948T LT 18014956 T LT18014956 T LT 18014956T LT 3573948 T LT3573948 T LT 3573948T
Authority
LT
Lithuania
Prior art keywords
cytotoxic
preparation
methods
benzodiazepin
derivatives
Prior art date
Application number
LTEPPCT/US2018/014956T
Other languages
English (en)
Inventor
Baudouin GÉRARD
Richard Silva
Michael Miller
Manami Shizuka
Original Assignee
Immunogen, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen, Inc. filed Critical Immunogen, Inc.
Publication of LT3573948T publication Critical patent/LT3573948T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/19Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/16Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/448Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
    • C07D207/452Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
LTEPPCT/US2018/014956T 2017-01-25 2018-01-24 Citotoksinių benzodiazepino darinių paruošimo būdai LT3573948T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762450270P 2017-01-25 2017-01-25
PCT/US2018/014956 WO2018140435A1 (en) 2017-01-25 2018-01-24 Methods of preparing cytotoxic benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
LT3573948T true LT3573948T (lt) 2023-02-10

Family

ID=61189535

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/US2018/014956T LT3573948T (lt) 2017-01-25 2018-01-24 Citotoksinių benzodiazepino darinių paruošimo būdai

Country Status (24)

Country Link
US (4) US10385071B2 (lt)
EP (2) EP4148044A1 (lt)
JP (3) JP7066725B2 (lt)
KR (2) KR102480594B1 (lt)
CN (3) CN116554262A (lt)
AU (3) AU2018213202B2 (lt)
CA (1) CA3050262A1 (lt)
CY (1) CY1125759T1 (lt)
DK (1) DK3573948T3 (lt)
ES (1) ES2935346T3 (lt)
FI (1) FI3573948T3 (lt)
HR (1) HRP20230002T1 (lt)
HU (1) HUE060746T2 (lt)
IL (3) IL293645A (lt)
LT (1) LT3573948T (lt)
PL (1) PL3573948T3 (lt)
PT (1) PT3573948T (lt)
RS (1) RS63871B1 (lt)
RU (2) RU2762891C2 (lt)
SG (1) SG11201906666QA (lt)
SI (1) SI3573948T1 (lt)
SM (1) SMT202300001T1 (lt)
TW (3) TWI805325B (lt)
WO (1) WO2018140435A1 (lt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4148044A1 (en) 2017-01-25 2023-03-15 ImmunoGen, Inc. Methods of preparing cytotoxic benzodiazepine derivatives
KR20210098470A (ko) * 2018-11-12 2021-08-10 이뮤노젠 아이엔씨 세포독성 벤조디아제핀 유도체의 제조 방법
TWI849000B (zh) 2018-11-12 2024-07-21 美商伊繆諾金公司 製備細胞毒性苯二氮呯衍生物之方法
EP3947395A1 (en) * 2019-03-29 2022-02-09 ImmunoGen, Inc. Cytotoxic bis-benzodiazepine derivatives and conjugates thereof with cell-binding agents for inhibiting abnormal cell growth or for treating proliferative diseases
KR20250031149A (ko) 2022-06-30 2025-03-06 도레이 카부시키가이샤 암의 치료 및/또는 예방용 의약 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9018601D0 (en) 1990-08-24 1990-10-10 Fujisawa Pharmaceutical Co Tricyclic compounds
EP2668187B1 (en) 2010-12-21 2014-10-15 Janssen Pharmaceutica, N.V. NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]- BENZODIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH BICYCLIC BENZENE DERIVATIVES
JP6049642B2 (ja) * 2011-02-15 2016-12-21 イミュノジェン・インコーポレーテッド 複合体の調製方法
TW201632531A (zh) * 2015-01-14 2016-09-16 必治妥美雅史谷比公司 苯二氮呯二聚物,其結合物及製造與使用方法
ES2887273T3 (es) 2015-06-29 2021-12-22 Immunogen Inc Anticuerpos anti-CD123 y conjugados y derivados de los mismos
SG10202106529XA (en) 2015-07-21 2021-07-29 Immunogen Inc Methods of preparing cytotoxic benzodiazepine derivatives
EP4148044A1 (en) 2017-01-25 2023-03-15 ImmunoGen, Inc. Methods of preparing cytotoxic benzodiazepine derivatives

Also Published As

Publication number Publication date
JP2022105096A (ja) 2022-07-12
JP2020505404A (ja) 2020-02-20
FI3573948T3 (fi) 2023-01-13
IL268213A (en) 2019-09-26
IL287405B (en) 2022-07-01
EP3573948B1 (en) 2022-10-05
IL287405A (en) 2021-12-01
CN110225904B (zh) 2023-10-27
TWI763771B (zh) 2022-05-11
US20230039161A1 (en) 2023-02-09
RU2762891C2 (ru) 2021-12-23
AU2022201572B2 (en) 2024-03-14
RU2019125133A (ru) 2021-02-26
US20200002360A1 (en) 2020-01-02
HRP20230002T1 (hr) 2023-02-17
PT3573948T (pt) 2023-01-11
CY1125759T1 (el) 2026-02-25
HUE060746T2 (hu) 2023-04-28
RU2021138005A (ru) 2022-01-18
AU2022201572A1 (en) 2022-03-31
CN110225904A (zh) 2019-09-10
CN116102615A (zh) 2023-05-12
DK3573948T3 (da) 2023-01-09
SG11201906666QA (en) 2019-08-27
ES2935346T3 (es) 2023-03-06
CA3050262A1 (en) 2018-08-02
WO2018140435A1 (en) 2018-08-02
TWI805325B (zh) 2023-06-11
KR20190116331A (ko) 2019-10-14
US10844078B2 (en) 2020-11-24
JP7066725B2 (ja) 2022-05-13
KR20230005410A (ko) 2023-01-09
RS63871B1 (sr) 2023-02-28
AU2018213202A1 (en) 2019-08-22
SMT202300001T1 (it) 2023-03-17
JP7400005B2 (ja) 2023-12-18
IL293645A (en) 2022-08-01
US20180251474A1 (en) 2018-09-06
AU2024201119A1 (en) 2024-03-14
PL3573948T3 (pl) 2023-01-30
IL268213B (en) 2021-12-01
KR102480594B1 (ko) 2022-12-26
TW202229226A (zh) 2022-08-01
US11981687B2 (en) 2024-05-14
CN116554262A (zh) 2023-08-08
US11390633B2 (en) 2022-07-19
JP2024028860A (ja) 2024-03-05
WO2018140435A9 (en) 2018-12-27
US20210139510A1 (en) 2021-05-13
EP3573948A1 (en) 2019-12-04
SI3573948T1 (sl) 2023-03-31
US10385071B2 (en) 2019-08-20
EP4148044A1 (en) 2023-03-15
RU2019125133A3 (lt) 2021-05-27
TW202400551A (zh) 2024-01-01
TW201831495A (zh) 2018-09-01
AU2018213202B2 (en) 2022-03-24

Similar Documents

Publication Publication Date Title
IL283777A (en) Methods for formulating antibody drug conjugate compositions
DK3189056T3 (da) Cytotoksiske benzodiazepinderivater
IL286788A (en) Methods for the preparation of cytotoxic benzodiazepine compounds
PT3457851T (pt) Derivados de sobetiroma
HUE050974T2 (hu) Eljárás pirimidinszulfamid-származékok elõállítására
PL3625224T3 (pl) Pochodne n-podstawionego indolu
IL287405A (en) Methods of preparing cytotoxic benzodiazepine derivatives
FR3023290B1 (fr) Derives de flavaglines
PT3143018T (pt) Derivados da caboxamida
IL287119B1 (en) Bryostatin compounds and methods of preparing the same
EP3448375C0 (en) BENZOYLGLYCINE DERIVATIVES AND METHODS OF PRODUCING AND USING SUCH DERIVATIVES
IL293192A (en) Methods for the preparation of indolinobenzodiazepine derivatives
DK3625231T3 (da) Derivatives of resiquimod
ES2819424T8 (es) Métodos de preparación de ciclohexanona y derivados